Q-Line Biotech Limited, a active public limited company, was established on 10 November 2010 in Lucknow, Uttar Pradesh, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U74120UP2010PLC042528. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹16.27 Cr.
Formerly known as Poct Services Private Limited, Sperogenx Lifesciences Private Limited. It upholds a compliant status. Employing 219 professional, Its leadership includes Ayush Garg (Director), Kuldeep Chowdhry (Director), Pravir Kumar (Director). Past directors included Manisha Yadav, Ayush Garg, Kuldeep Chowdhry. It holds ₹191.56 Cr open charges and ₹18.72 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh, 226012.
U74120UP2010PLC042528
042528
10 November 2010
₹25.00 Cr
₹16.27 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Q-Line Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ayush Garg | Director | 01 Jul 2023 | Current |
| Kuldeep Chowdhry | Director | 12 Jan 2015 | Current |
| Pravir Kumar | Director | 08 May 2025 | Current |
| Yethadka Subraya Prabhakara | Whole-Time Director | 08 May 2025 | Current |
| Saurabh Garg | Director | 10 Nov 2010 | Current |
| Abhishek Mishra | Director | 08 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2015 | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Q-Line Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.7% decrease. The company also saw a substantial fall in profitability, with a 49.13% decrease in profit. The company's net worth Soared by an impressive increase of 24.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Q-Line Biotech had a promoter holding of 95.24% and a public holding of 4.76%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,915,585,650.00
₹187,167,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 May 2024 | Others | ₹2.50 M | Open |
| 21 Mar 2024 | Others | ₹6.75 Cr | Open |
| 20 Mar 2024 | Others | ₹18.00 Cr | Open |
| 11 Dec 2023 | Hdfc Bank Limited | ₹1.61 M | Open |
| 27 Feb 2023 | Hdfc Bank Limited | ₹2.03 M | Open |
Explore comprehensive loan charge details -
Q-Line Biotech has a workforce of 219 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Q-Line Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Q-Line Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 155.77 Cr registered on 13 Mar 2019 with Charge ID 100255677 was modified on 29 Sep 2025. was completed.
Progress on Akhand Pratap Singh was appointed as a Company Secretary was appointed as a Company Secretary on 20 Aug 2025 & has been associated with this company since 3 months 27 days . was documented.
Meenal Gupta was appointed as a Cfo was appointed as a Cfo on 20 Aug 2025 & has been associated with this company since 3 months 27 days . was recorded as a recent event.
The activity Jai Prakash Singh was appointed as a Director was appointed as a Director on 01 Aug 2025 & has been associated with this company since 4 months 16 days . was completed.
A charge registered on 26 Oct 2021 via Charge ID 100492576 with Others was fully satisfied on 03 Jul 2025. was recorded as a recent event.
Progress on Pravir Kumar was appointed as a Director was appointed as a Director on 08 May 2025 & has been associated with this company since 7 months 9 days . was documented.
The CIN of Q-Line Biotech Limited is U74120UP2010PLC042528.
Q-Line Biotech Limited is headquartered at 298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh, 226012.
Q-Line Biotech Limited was incorporated on 10 November 2010.
The current directors of Q-Line Biotech Limited are
The primary industry of Q-Line Biotech Limited is Trade.
Q-Line Biotech Limited is unlisted.
The authorized capital of Q-Line Biotech Limited is ₹25.00 Cr, and the paid-up capital is ₹16.27 Cr.
The compliance status of Q-Line Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX